Respiratory Manifestations of Strongyloidiasis: Significance of Diagnosis, Treatment, and Screening
- PMID: 40225532
- PMCID: PMC11994047
- DOI: 10.7759/cureus.80557
Respiratory Manifestations of Strongyloidiasis: Significance of Diagnosis, Treatment, and Screening
Abstract
Strongyloidiasis is a widespread disease characterized clinically by acute or chronic manifestations, which, in high-risk individuals and immunocompromised individuals, can progress to hyperinfection syndrome and disseminated forms with significant mortality rates. Among extraintestinal organs, the lungs are most commonly affected. Clinical presentations are very diverse, contributing to the challenges of diagnosis and timely treatment initiation. We present the case of a 57-year-old patient who was admitted to the intensive care unit (ICU) due to bilateral pneumonia and septic shock. During a two-month hospitalization period, the patient spent 16 days on invasive mechanical ventilation. Initially, nonspecific symptoms, such as weakness, fatigue, and cough, evolved into complications, including diarrheal syndrome, hemoptysis, urticaria, and ventilator-associated pneumonia (VAP) caused by Gram-negative bacteria. Numerous larvae of Strongyloides stercoralis were identified in a stool sample. In addition to antibiotic therapy, antiparasitic treatment was administered, resulting in significant improvement in the patient's overall condition, leading to discharge for further home care. In this case, community-acquired pneumonia was complicated by the reactivation of chronic strongyloidiasis in the form of hyperinfection syndrome in a high-risk patient. High-risk individuals and immunocompromised individuals should undergo screening for parasitic infections in cases presenting with gastrointestinal symptoms, particularly diarrhea and respiratory symptoms. Screening for parasitic infections should be integrated into routine clinical practice for this population.
Keywords: diarrhea; hyperinfection syndrome; pneumonia; screening; strongyloides stercoralis.
Copyright © 2025, Banjac et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
References
-
- Strongyloidiasis. [ Mar; 2025 ]. 2018. https://www.cdc.gov/strongyloides/about/index.html https://www.cdc.gov/strongyloides/about/index.html
-
- Toledo R, Muñoz-Antoli C, Esteban JG. Advances in Parasitology. Vol. 88. Cambridge, MA: Academic Press; 2015. Chapter five - Strongyloidiasis with emphasis on human infections and its different clinical forms; pp. 165–241. - PubMed
Publication types
LinkOut - more resources
Full Text Sources